May 22, 2020
The Lancet
This paper has been retracted.
“Interpretation: We were unable to confirm a benefit of hydroxychloroquine or chloroquine, when used alone or with a macrolide, on in-hospital outcomes for COVID-19. Each of these drug regimens was associated with decreased in-hospital survival and an increased frequency of ventricular arrhythmias when used for treatment of COVID-19.”
All content on this site: Copyright © 2023 Elsevier Ltd., its licensors, and contributors.All rights are reserved, including those for text and data mining, AI training, and similar technologies. For all open access content, the Creative Commons licensing terms apply.
document
COVID-19,hydroxychloroquine,medical treatments